Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash Flows from Operating Activities:
Net income	$ 8,816	$ 4,979
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,887	1,489
Provision for bad debts (for cash flow statement)	7,894	735
Stock issued for costs and expenses	407
Compensatory element of stock issuances	86	395
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivables	(11,012)	(3,552)
Notes receivable	75	82
Costs and estimated earnings in excess of billings on uncompleted contracts	(236)	640
Inventories	(433)	(89)
Prepaid expenses and other current assets	31	(615)
Other assets	63	(183)
Increase (decrease) in operating liabilities, net:
Accounts payable	110	515
Other current liabilities	964	1,214
Customer advances	(67)	882
Other liabilities	(221)	(39)
Due to related medical practices	1	2
Income tax payable	(20)	(100)
Net cash provided by operating activities	9,345	6,355
Cash Flows from Investing Activities:
Purchases of property and equipment	(375)	(568)
Cost of HDM Acquisition		(40,000)
Cost of patents	(172)	(109)
Proceeds from non controlling interests		19,800
Net cash used in investing activities	(547)	(20,877)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(3,401)	(983)
Stock option Exercised	31
Distributions to non controlling interests	(3,724)	(1,298)
Proceeds from long-term debt		14,000
Repayment of notes receivable from employee Stockholders	14	14
Net cash (used in) provided by financing activities	(7,080)	11,733
Net (Decrease) Increase in Cash and Cash Equivalents	1,718	(2,789)
Cash and Cash Equivalents - Beginning of Period	7,871	12,032
Cash and Cash Equivalents - End of Period	$ 9,589	$ 9,243